Targeting orphan nuclear receptor SHP in the treatment of metabolic diseases
Authors:
- Mi-Kyung KimMKMi-Kyung Kim
- Dipanjan ChandaDCDipanjan Chanda
- In-Kyu LeeILIn-Kyu Lee
- Hueng-Sik ChoiHCHueng-Sik Choi
- Keun-Gyu ParkKPKeun-Gyu Park
- 10 February 2010
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 14 (4) , 453-466
Abstract
Importance of the field: The orphan nuclear receptor small heterodimer partner (SHP; NR0B2) is an atypical nuclear receptor that contains a ligand-binding domain, but lacks the conserved DNA-binding domain. Since its discovery, SHP has been identified as a key transcriptional regulatory factor of genes involved in diverse metabolic pathways. Areas covered in this review: We performed a Medline/Pubmed search to find published studies on the role of SHP in the regulation of metabolism in the liver, pancreatic islets, blood vessel, and kidney and on the feasibility of using SHP as a therapeutic target in metabolic disease. What the reader will gain: In this review, we discuss the function of SHP as regulator of cholesterol, lipid and glucose metabolism, and the role of SHP in metabolic and fibrotic diseases. Take home message: The reviewed studies suggested that SHP could be a major target for therapeutic intervention in metabolic and fibrotic diseases, including metabolic syndrome and its complications. However, for SHP-targeted therapy, there are some outstanding issues, including the small number of known inducers of SHP and the lack of sufficient data in humans.Keywords
This publication has 115 references indexed in Scilit:
- Hepatocyte Growth Factor Family Negatively Regulates Hepatic Gluconeogenesis via Induction of Orphan Nuclear Receptor Small Heterodimer Partner in Primary HepatocytesJournal of Biological Chemistry, 2009
- Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate–activated protein kinase–dependent induction of orphan nuclear receptor small heterodimer partner #Hepatology, 2009
- Kidney Pathological Changes in Metabolic Syndrome: A Cross-sectional StudyAmerican Journal of Kidney Diseases, 2009
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasisHepatology, 2008
- The CREB coactivator TORC2 is a key regulator of fasting glucose metabolismNature, 2005
- Inflammation in atherosclerosisNature, 2002
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001
- Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying DiseaseHepatology, 1999
- Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1)Nature, 1996